Discovery of potential novel microsomal triglyceride transfer protein inhibitors via virtual screening of pharmacophore modelling and molecular docking

被引:13
作者
Jiang, Ludi [1 ]
He, Yusu [1 ]
Luo, Ganggang [1 ]
Yang, Yongqiang [1 ]
Li, Gongyu [1 ]
Zhang, Yanling [1 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Key Lab TCM Informat Engineer State Adm TCM, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
MTP inhibitors; pharmacophore; virtual screening; homology modeling; docking; traditional Chinese medicine; MTP INHIBITORS; FAMILIAL HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN-B; NICOTINIC-ACID; BINDING-SITE; CHOLESTEROL; SECRETION; MECHANISM; SAFETY;
D O I
10.1080/08927022.2016.1149701
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In order to identify potential natural inhibitors against the microsomal triglyceride transfer protein (MTP), HipHop models were generated using 20 known inhibitors from the Binding Database. Using evaluation indicators, the best hypothesis model, Hypo1, was selected and utilised to screen the Traditional Chinese Medicine Database, which resulted in a hit list of 58 drug-like compounds. A homology model of MTP was built by MODELLER and was minimised by CHARMm force field. It was then validated by Ramachandran plot and Verify-3D so as to obtain a stable structure, which was further used to refine the 58 hits using molecular docking studies. Then, five compounds with higher docking scores which satisfied the docking requirements were discovered. Among them, Ginkgetin and Dauricine were most likely to be candidates that exhibition inhibiting effect on MTP. The screening strategy in this study is relatively new to the discovery of MTP inhibitors in medicinal chemistry. Moreover, it is important to note that, lomitapide, an approved MTP inhibitor, fits well with Hypo1 as well as our homology model of MTP, which confirmed the rationality of our studies. The results indicated the applicability of molecular modeling for the discovery of potential natural MTP inhibitors from traditional Chinese herbs.
引用
收藏
页码:1223 / 1232
页数:10
相关论文
共 43 条
[1]   The Role of Microsomal Triglyceride Transfer Protein Inhibitors in the Treatment of Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management [J].
Ahmad, Zahid ;
Khera, Amit .
CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (01)
[2]   Rhabdomyolysis and Acute Kidney Injury Associated with Hypothyroidism and Statin Therapy [J].
Ahn, Pyoung ;
Min, Hyun-Jun ;
Park, Sang-Hyun ;
Lee, Byoung-Mu ;
Choi, Myung-Jin ;
Yoon, Jong-Woo ;
Koo, Ja-Ryong .
ENDOCRINOLOGY AND METABOLISM, 2013, 28 (04) :331-334
[3]   The structural basis of lipid interactions in lipovitellin, a soluble lipoprotein [J].
Anderson, TA ;
Levitt, DG ;
Banaszak, LJ .
STRUCTURE WITH FOLDING & DESIGN, 1998, 6 (07) :895-909
[4]   Pharmacophore model generation of HMG-CoA reductase inhibitors [J].
Bao Hong-Juan ;
Zhang Yan-Ling ;
Qiao Yan-Jiang .
ACTA PHYSICO-CHIMICA SINICA, 2008, 24 (02) :301-306
[5]  
Birjmohun RS, 2004, NETH J MED, V62, P229
[6]   A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomerase [J].
Bradbury, P ;
Mann, CJ ;
Köchl, S ;
Anderson, TA ;
Chester, SA ;
Hancock, JM ;
Ritchie, PJ ;
Amey, J ;
Harrison, GB ;
Levitt, DG ;
Banaszak, LJ ;
Scott, J ;
Shoulders, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) :3159-3164
[7]   Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study [J].
Cuchel, Marina ;
Meagher, Emma A. ;
Theron, Hendrik du Toit ;
Blom, Dirk J. ;
Marais, A. David ;
Hegele, Robert A. ;
Averna, Maurizio R. ;
Sirtori, Cesare R. ;
Shah, Prediman K. ;
Gaudet, Daniel ;
Stefanutti, Claudia ;
Vigna, Giovanni B. ;
Du Plessis, Anna M. E. ;
Propert, Kathleen J. ;
Sasiela, William J. ;
Bloedon, LeAnne T. ;
Rader, Daniel J. .
LANCET, 2013, 381 (9860) :40-46
[8]  
Drwal Malgorzata N, 2013, Drug Discov Today Technol, V10, pe395, DOI 10.1016/j.ddtec.2013.02.002
[9]   Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion [J].
Fisher, Eric ;
Lake, Elizabeth ;
McLeod, Roger S. .
JOURNAL OF BIOMEDICAL RESEARCH, 2014, 28 (03) :178-193
[10]  
Florentin M, 2008, CURR PHARM DESIGN, V14, P574